News

In the first quarter of 2025, 29.7 million transactions were made in the Latvian Medicines Verification System (LZVS), which is slightly more than in the corresponding period of 2024.

Representatives of Arvato Customer Group countries met with system developer Arvato Systems GmbH in Vienna, Austria, on 25 and 26 March to plan further improvements in the National Medicines Verification System.

On 30 January 2025, Arvato Systems held a webinar for IT developers to inform them about the planned updates to the LZVS. Updates will be introduced with the release of Core NMVS 6.0.

To inform partners, Software Suppliers (SWS) about novelties of the medicines verification system in Latvia and EU and future development plans, the Latvian Medicines Verification Organisation (LZVO) held a special seminar on September 18.

On February 22, the Latvian Medicines Verification Organisation (LZVO) held a free seminar for manufacturers of medicines or marketing authorization holders (MAH) on the current developments related to the medicines verification system in Latvia and a look back on what was done in 2022.

To inform marketing authorization holders (MAHs) about the current events, the Latvian Medicines Verification Organisation (LZVO) will hold a special seminar on February 22, 2023.